Yewen Xie

Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

ENO3-mediated glycolytic reprogramming participates in β-glucan-induced dendritic cells activation and anti-tumor responses.

ENO3-mediated glycolytic reprogramming participates in β-glucan-induced dendritic cells activation and anti-tumor responses.

Journal: Cellular and molecular life sciences : CMLS
Published: February 13, 2026

SerpinB9 sustains CIITA to orchestrate MHC-II expression and Th1 differentiation in β-glucan-induced macrophages.

SerpinB9 sustains CIITA to orchestrate MHC-II expression and Th1 differentiation in β-glucan-induced macrophages.

Journal: Immunologic research
Published: August 27, 2025

Collagen heterogeneity: a barrier and bridge driving tumor immune microenvironment remodeling.

Collagen heterogeneity: a barrier and bridge driving tumor immune microenvironment remodeling.

Journal: Immunologic research
Published: December 02, 2024

Sulforaphane Attenuates AOM/DSS-Induced Colorectal Tumorigenesis in Mice via Inhibition of Intestinal Inflammation.

Sulforaphane Attenuates AOM/DSS-Induced Colorectal Tumorigenesis in Mice via Inhibition of Intestinal Inflammation.

Journal: Nutrition and cancer
Published: October 28, 2023

Whole β-glucan particle attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation.

Whole β-glucan particle attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation.

Journal: Frontiers in pharmacology
Published: August 12, 2022

Inhibition of TFEB promotes tumor-educated dendritic cells activation to enhance antitumor immune responses.

Inhibition of TFEB promotes tumor-educated dendritic cells activation to enhance antitumor immune responses.

Journal: Molecular immunology
Published: September 15, 2021

HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment.

HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment.

Journal: Journal for immunotherapy of cancer
Published: May 14, 2020

Tumor exosomes block dendritic cells maturation to decrease the T cell immune response.

Tumor exosomes block dendritic cells maturation to decrease the T cell immune response.

Journal: Immunology letters
Published: January 24, 2018

miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.

miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.

Journal: Oncotarget
Published: November 01, 2015
Showing 1-9 of 9

Last Updated: 09/26/2026